TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0130nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0160nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0210nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0230nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0250nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0250nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0270nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0300nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0330nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0340nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0500nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0520nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0580nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0600nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0660nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0780nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0830nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0900nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.0930nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.110nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.140nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.180nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.210nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.220nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.25nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.270nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.5nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.720nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.850nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 0.900nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
TargetNeutrophil elastase(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:Potency of inhibition of human leukocyte elastase is expressed as apparent binding constantMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 2.80nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 3.40nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 3.5nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 5.90nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 6.90nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 7.80nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes.More data for this Ligand-Target Pair